Literature DB >> 20374068

Temporal stability of urinary and plasma biomarkers of tobacco smoke exposure among cigarette smokers.

Timothy R Church1, Kristin E Anderson, Chap Le, Yan Zhang, Diane M Kampa, Adam R Benoit, Andrea R Yoder, Steven G Carmella, Stephen S Hecht.   

Abstract

Intraindividual variability of measurements of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), nicotine, cotinine, and r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene (PheT) over time is uncertain. From 70 habitual smokers' plasma and urine sampled bimonthly for a year we analysed plasma for NNAL, cotinine and PheT, and urine for NNAL, cotinine and nicotine. We estimated the intraclass correlation coefficients (rho(I)) for each measurement. Plasma and creatinine-corrected urinary NNAL were stable (rho(I) > or =70%); plasma PheT and plasma and urinary total cotinine were fairly stable (rho(I) > or =50%), but urinary nicotine rho(I) approximately 40% was not. Except for nicotine, single measurements from plasma or urine adequately represent individual mean exposure over time.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20374068      PMCID: PMC2871960          DOI: 10.3109/13547501003753881

Source DB:  PubMed          Journal:  Biomarkers        ISSN: 1354-750X            Impact factor:   2.658


  24 in total

1.  Relationship between machine-derived smoke yields and biomarkers in cigarette smokers in Germany.

Authors:  Gerhard Scherer; Johannes Engl; Michael Urban; Gerhard Gilch; Dinamis Janket; Kirsten Riedel
Journal:  Regul Toxicol Pharmacol       Date:  2006-10-10       Impact factor: 3.271

2.  Population estimates for biomarkers of exposure to cigarette smoke in adult U.S. cigarette smokers.

Authors:  Hans J Roethig; Sagar Munjal; Shixia Feng; Qiwei Liang; Mohamadi Sarkar; Ruediger-A Walk; Paul E Mendes
Journal:  Nicotine Tob Res       Date:  2009-08-21       Impact factor: 4.244

3.  Combined analysis of r-1,t-2,3,c-4-tetrahydroxy-1,2,3,4-tetrahydrophenanthrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in smokers' plasma.

Authors:  Steven G Carmella; Andrea Yoder; Stephen S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

Review 4.  Tobacco carcinogens, their biomarkers and tobacco-induced cancer.

Authors:  Stephen S Hecht
Journal:  Nat Rev Cancer       Date:  2003-10       Impact factor: 60.716

5.  Simultaneous determination of four tobacco-specific N-nitrosamines (TSNA) in human urine.

Authors:  Dominique Kavvadias; Gerhard Scherer; Michael Urban; Francis Cheung; Graham Errington; Jim Shepperd; Mike McEwan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-03-16       Impact factor: 3.205

6.  Effects of smoking cessation on eight urinary tobacco carcinogen and toxicant biomarkers.

Authors:  Steven G Carmella; Menglan Chen; Shaomei Han; Anna Briggs; Joni Jensen; Dorothy K Hatsukami; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2009-04       Impact factor: 3.739

7.  A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers.

Authors:  Timothy R Church; Kristin E Anderson; Neil E Caporaso; Mindy S Geisser; Chap T Le; Yan Zhang; Adam R Benoit; Steven G Carmella; Stephen S Hecht
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

Review 8.  Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer.

Authors:  Stephen S Hecht
Journal:  Carcinogenesis       Date:  2002-06       Impact factor: 4.944

9.  Analysis of [3',3'-d(2)]-nicotine and [3',3'-d(2)]-cotinine by capillary liquid chromatography-electrospray tandem mass spectrometry.

Authors:  Sharon E Murphy; Peter Villalta; Sing-Wei Ho; Linda B von Weymarn
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-06-29       Impact factor: 3.205

10.  Similar exposure to a tobacco-specific carcinogen in smokeless tobacco users and cigarette smokers.

Authors:  Stephen S Hecht; Steven G Carmella; Sharon E Murphy; William T Riley; Chap Le; Xianghua Luo; Marc Mooney; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-08       Impact factor: 4.254

View more
  20 in total

1.  The ratio of a urinary tobacco-specific lung carcinogen metabolite to cotinine is significantly higher in passive than in active smokers.

Authors:  Rachel I Vogel; Steven G Carmella; Irina Stepanov; Dorothy K Hatsukami; Stephen S Hecht
Journal:  Biomarkers       Date:  2011-08-03       Impact factor: 2.658

Review 2.  Biomarkers of exposure to new and emerging tobacco delivery products.

Authors:  Suzaynn F Schick; Benjamin C Blount; Peyton Jacob; Najat A Saliba; John T Bernert; Ahmad El Hellani; Peter Jatlow; R Steven Pappas; Lanqing Wang; Jonathan Foulds; Arunava Ghosh; Stephen S Hecht; John C Gomez; Jessica R Martin; Clementina Mesaros; Sanjay Srivastava; Gideon St Helen; Robert Tarran; Pawel K Lorkiewicz; Ian A Blair; Heather L Kimmel; Claire M Doerschuk; Neal L Benowitz; Aruni Bhatnagar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-05-18       Impact factor: 5.464

3.  Urinary N7-(1-hydroxy-3-buten-2-yl) guanine adducts in humans: temporal stability and association with smoking.

Authors:  Caitlin C Jokipii Krueger; Guru Madugundu; Amanda Degner; Yesha Patel; Daniel O Stram; Timothy R Church; Natalia Tretyakova
Journal:  Mutagenesis       Date:  2020-02-13       Impact factor: 3.000

4.  Tobacco smoke biomarkers and cancer risk among male smokers in the Shanghai cohort study.

Authors:  Stephen S Hecht; Sharon E Murphy; Irina Stepanov; Heather H Nelson; Jian-Min Yuan
Journal:  Cancer Lett       Date:  2012-07-20       Impact factor: 8.679

5.  Chapter 6: Lung cancer in never smokers: epidemiology and risk prediction models.

Authors:  William J McCarthy; Rafael Meza; Jihyoun Jeon; Suresh H Moolgavkar
Journal:  Risk Anal       Date:  2012-07       Impact factor: 4.000

Review 6.  Oral Cell DNA Adducts as Potential Biomarkers for Lung Cancer Susceptibility in Cigarette Smokers.

Authors:  Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2016-12-01       Impact factor: 3.739

7.  High throughput liquid and gas chromatography-tandem mass spectrometry assays for tobacco-specific nitrosamine and polycyclic aromatic hydrocarbon metabolites associated with lung cancer in smokers.

Authors:  Steven G Carmella; Xun Ming; Natalie Olvera; Claire Brookmeyer; Andrea Yoder; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2013-07-24       Impact factor: 3.739

8.  Urinary levels of volatile organic carcinogen and toxicant biomarkers in relation to lung cancer development in smokers.

Authors:  Jian-Min Yuan; Yu-Tang Gao; Renwei Wang; Menglan Chen; Steven G Carmella; Stephen S Hecht
Journal:  Carcinogenesis       Date:  2012-01-31       Impact factor: 4.944

9.  Quantitation of a minor enantiomer of phenanthrene tetraol in human urine: correlations with levels of overall phenanthrene tetraol, benzo[a]pyrene tetraol, and 1-hydroxypyrene.

Authors:  J Bradley Hochalter; Yan Zhong; Shaomei Han; Steven G Carmella; Stephen S Hecht
Journal:  Chem Res Toxicol       Date:  2011-01-13       Impact factor: 3.739

10.  Longitudinal study of [D10]phenanthrene metabolism by the diol epoxide pathway in smokers.

Authors:  Stephen S Hecht; J Bradley Hochalter; Steven G Carmella; Yan Zhang; Diane M Rauch; Naomi Fujioka; Joni Jensen; Dorothy K Hatsukami
Journal:  Biomarkers       Date:  2013-01-22       Impact factor: 2.658

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.